Literature DB >> 9231728

Effects of ketone bodies on astrocyte amino acid metabolism.

M Yudkoff1, Y Daikhin, I Nissim, R Grunstein, I Nissim.   

Abstract

The effects of acetoacetate and 3-hydroxybutyrate on glial amino acid metabolism were studied in primary cultures of astrocytes. The exchange of nitrogen among amino acids was measured with 15N as a metabolic probe and gas chromatography-mass spectrometry as a tool with which to quantify isotope abundance. Addition of either acetoacetate or 3-hydroxybutyrate (5 mM) to the incubation medium did not alter the initial rate of appearance of [15N]glutamate in the glia, but it did inhibit transamination of glutamate to [15N]aspartate. Addition of acetoacetate also inhibited formation of [2-(15)N]glutamine, but 3-hydroxybutyrate had a stimulatory effect. The presence in the medium of sodium acetate (5 mM) was also associated with diminished production of [15N]aspartate and [2-(15)N]glutamine with [15N]glutamate as precursor. Studies with [2-(15)N]glutamine as precursor indicated that treatment of the astrocytes with ketone bodies did not alter flux through the glutaminase pathway. Nor did the presence of the ketone bodies reduce significantly the flux of nitrogen from [15N]GABA to [2-(15)N]glutamine when the former species served as a metabolic tracer. The concentration of internal citrate increased in the presence of acetoacetate, 3-hydroxybutyrate, and acetate. Studies with purified sheep brain glutamine synthetase showed that citrate inhibited this enzyme. These findings are considered in terms of the known anticonvulsant effect of a ketogenic diet.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231728     DOI: 10.1046/j.1471-4159.1997.69020682.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

Review 1.  Ketone bodies in epilepsy.

Authors:  Melanie A McNally; Adam L Hartman
Journal:  J Neurochem       Date:  2012-02-07       Impact factor: 5.372

Review 2.  Cerebral metabolic adaptation and ketone metabolism after brain injury.

Authors:  Mayumi L Prins
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-08       Impact factor: 6.200

Review 3.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

4.  β-Hydroxybutyrate Boosts Mitochondrial and Neuronal Metabolism but is not Preferred Over Glucose Under Activated Conditions.

Authors:  Lavanya B Achanta; Benjamin D Rowlands; Donald S Thomas; Gary D Housley; Caroline D Rae
Journal:  Neurochem Res       Date:  2017-03-18       Impact factor: 3.996

5.  A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat.

Authors:  Yoshihiro Kashiwaya; Robert Pawlosky; William Markis; M Todd King; Christian Bergman; Shireesh Srivastava; Andrew Murray; Kieran Clarke; Richard L Veech
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

Review 6.  The biochemistry of ketogenesis and its role in weight management, neurological disease and oxidative stress.

Authors:  Peter Andrew C McPherson; Jane McEneny
Journal:  J Physiol Biochem       Date:  2011-10-08       Impact factor: 4.158

Review 7.  β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms.

Authors:  Lavanya B Achanta; Caroline D Rae
Journal:  Neurochem Res       Date:  2016-11-08       Impact factor: 3.996

Review 8.  β-Hydroxybutyrate: A Signaling Metabolite.

Authors:  John C Newman; Eric Verdin
Journal:  Annu Rev Nutr       Date:  2017-08-21       Impact factor: 11.848

Review 9.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 10.  Ketosis and brain handling of glutamate, glutamine, and GABA.

Authors:  Marc Yudkoff; Yevgeny Daikhin; Oksana Horyn; Ilana Nissim; Itzhak Nissim
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.